跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2025/02/081121
CTRI/2025/02/081121尚未招募不适用

COMPARATIVE STUDY OF EFFECT OF MARMA CHIKITSA AS ADD-ON THERAPY ON DIABETES MELLITUS TYPE 2 SUBJECTS ON BLOOD SUGAR LEVEL AND QUALITY OF LIFE PARAMETERS”

UPGIASR RAU Jodhpur Rajasthan1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月3日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Change in BSL Or any symptoms
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Diabetes Mellitus is a global problem, and India is likely to be the diabetic capital of the world by 2030.  To address this global issue holistic, integrated approach is the need of the hour. present study is an attempt to see the effect of non-invasive classical Marma therapy (A unique method where a particular point is pressed in a desired way for a fixed time) on Blood Sugar Level or QOL or both.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)（—）
性别
All

入选标准

  • •1.Pre diabetic and diabetic 2.Patients who are on same medicine for longer duration.3.Individual which falls under diagnostic criteria.
  • •Already diagnosed cases of pre diabetic and diabetic
  • •individual willing to be registered for study.

排除标准

  • •1.Subject having any congenital elbow end wrist joint disorder.
  • •2.Pregnancy, Post Natal Care, Lactating women.
  • •& menstrual phase
  • •Chain smoker, heavy drinker.
  • •4.Subject having monoplegia, paraplegia.
  • •5.other associated condition.
  • •Traumatic, Infective, Neoplastic condition of patient.
  • •7.Individual suffering from infection like viral, bacterial and fungal.
  • •8.Individual who is suffering from any systemic or metabolic disorders (Hypertension, Tuberculosis, Thyroid).

结局指标

主要结局

Change in BSL Or any symptoms

时间窗: 90 days

次要结局

  • Changes in quality of life(12 week)

研究者

发起方
UPGIASR RAU Jodhpur Rajasthan
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Anish Kumar Pathak

Sri Sai Institute of Ayurvedic Research and Medicine

研究点 (1)

Loading locations...

相似试验

尚未招募
Phase 3 4
Managment of Madhumeha (Diabetes type 2) through Kutjadi Kashaya.
CTRI/2025/02/080421Govt Ayurveda College and Hospital Nipaniya Rewa50
尚未招募
2/3 期
The use of Nisha Aamlaki Powder and Brahmi Powder, combined with walking, to manage Type 2 Diabetes.
CTRI/2025/07/090043FIMS SGT University200
尚未招募
2/3 期
Effect of a Unani Herbal Medicine Chilbeenj on Blood Sugar Control in Patients with Type 2 Diabetes.
CTRI/2025/12/099559Government of TamilNadu74
尚未招募
2/3 期
Evaluation of Synergistic activity of Honey as Anti-Hyperglycemic when given with Triphala Kashaya in Pre-Diabetes.
CTRI/2025/02/080528DR GRAMA SRIRANGARAJU SAHANA60
尚未招募
2/3 期
Comparison of efficacy of two ayurveda drugs namely Truptighna dadhemani tablet and Nisha Amalaki churna in the management of Type 2 Diabetes mellitus
CTRI/2025/06/088739Shree swaminarayan ayurvedic college kalol40